Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Communications Medicine
|
January 22, 2026
Introducing iCatalog as a clinical decision support tool for collaborative pediatric precision oncology studies
Wenjun Kang, Lorena Lazo de la Vega, Hannah Comeau, et al.
JAMA Oncology
|
January 30, 2016
Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study
Marian H Harris, Steven G DuBois, Julia L Glade Bender, et al.
The New England Journal of Medicine
|
December 29, 2016
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas
Eva Dombi, Andrea Baldwin, Leigh J Marcus, et al.
Neuro-Oncology Practice
|
July 15, 2024
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases
Britt A E Dhaenens, Günter Heimann, Annette Bakker, et al.
Neuro-Oncology
|
April 25, 2022
Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity
Andrea M Gross, Brittany Glassberg, Pamela L Wolters, et al.
Pediatric Blood & Cancer
|
May 2, 2025
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors
Filemon S Dela Cruz, Elizabeth Fox, Steven G DuBois, et al.
The Oncologist
|
June 14, 2024
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G
Marie V Nelson, AeRang Kim, P Mickey Williams, et al.
American Journal of Medical Genetics. Part A
|
April 23, 2018
2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis
Michael J Fisher, Allan J Belzberg, Peter de Blank, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2026
SARC031: A Phase 2 Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST)
AeRang Kim, Karla V Ballman, Pamela L Wolters, et al.
The New England Journal of Medicine
|
March 19, 2020
Selumetinib in Children with Inoperable Plexiform Neurofibromas
Andrea M Gross, Pamela L Wolters, Eva Dombi, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Communications Medicine
|
January 22, 2026
Introducing iCatalog as a clinical decision support tool for collaborative pediatric precision oncology studies
Wenjun Kang, Lorena Lazo de la Vega, Hannah Comeau, et al.
JAMA Oncology
|
January 30, 2016
Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study
Marian H Harris, Steven G DuBois, Julia L Glade Bender, et al.
The New England Journal of Medicine
|
December 29, 2016
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas
Eva Dombi, Andrea Baldwin, Leigh J Marcus, et al.
Neuro-Oncology Practice
|
July 15, 2024
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases
Britt A E Dhaenens, Günter Heimann, Annette Bakker, et al.
Neuro-Oncology
|
April 25, 2022
Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity
Andrea M Gross, Brittany Glassberg, Pamela L Wolters, et al.
Pediatric Blood & Cancer
|
May 2, 2025
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors
Filemon S Dela Cruz, Elizabeth Fox, Steven G DuBois, et al.
The Oncologist
|
June 14, 2024
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G
Marie V Nelson, AeRang Kim, P Mickey Williams, et al.
American Journal of Medical Genetics. Part A
|
April 23, 2018
2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis
Michael J Fisher, Allan J Belzberg, Peter de Blank, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2026
SARC031: A Phase 2 Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST)
AeRang Kim, Karla V Ballman, Pamela L Wolters, et al.
The New England Journal of Medicine
|
March 19, 2020
Selumetinib in Children with Inoperable Plexiform Neurofibromas
Andrea M Gross, Pamela L Wolters, Eva Dombi, et al.
Page
of 7